Alixtra subcutaneous injection 2.5mg, manufactured by Sand Pharma, contains Fondaparinux sodium, a selective factor Xa inhibitor used for the prevention of deep vein thrombosis and pulmonary embolism. This injectable medicine has a YJ code of 3339400G2025 and a standard of 2.5 mg in 0.5 mL per tube.
Alixtra subcutaneous injection 2.5mg
Need more detailed information?
Contact TASAKI PHARMA for product sourcing, availability, or related support (English support available).